Literature DB >> 25716176

Early childhood measles vaccinations are not associated with paediatric IBD: a population-based analysis.

Souradet Y Shaw1, James F Blanchard1, Charles N Bernstein2.   

Abstract

BACKGROUND: Early childhood vaccinations have been hypothesized to contribute to the emergence of paediatric inflammatory bowel disease [IBD] in developed countries. Using linked population-based administrative databases, we aimed to explore the association between vaccination with measles-containing vaccines and the risk for IBD.
METHODS: This was a case-control study using the University of Manitoba IBD Epidemiology Database [UMIBDED]. The UMIBDED was linked to the Manitoba Immunization Monitoring System [MIMS], a population-based database of immunizations administered in Manitoba. All paediatric IBD cases in Manitoba, born after 1989 and diagnosed before March 31, 2008, were included. Controls were matched to cases on the basis of age, sex, and region of residence at time of diagnosis. Measles-containing vaccinations received in the first 2 years of life were documented, with vaccinations categorized as 'None' or 'Complete', with completeness defined according to Manitoba's vaccination schedule. Conditional logistic regression models were fitted to the data, with models adjusted for physician visits in the first 2 years of life and area-level socioeconomic status at case date.
RESULTS: A total of 951 individuals [117 cases and 834 controls] met eligibility criteria, with average age of diagnosis among cases at 11 years. The proportion of IBD cases with completed vaccinations was 97%, compared with 94% of controls. In models adjusted for physician visits and area-level socioeconomic status, no statistically significant association was detected between completed measles vaccinations and the risk of IBD (adjusted odds ratio [AOR]: 1.5; 95% confidence interval [CI]: 0.5-4.4; p = 0.419].
CONCLUSIONS: No significant association between completed measles-containing vaccination in the first 2 years of life and paediatric IBD could be demonstrated in this population-based study.
Copyright © 2015 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Crohn’s disease; epidemiology; inflammatory bowel disease; measles vaccine; ulcerative colitis

Mesh:

Substances:

Year:  2015        PMID: 25716176     DOI: 10.1093/ecco-jcc/jjv029

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  5 in total

Review 1.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

2.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20

3.  Neonatal Colonic Inflammation: An Epigenetic Trigger of Adult Disease.

Authors:  Warren Strober
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-03-21

4.  The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.

Authors:  Matthew W Carroll; M Ellen Kuenzig; David R Mack; Anthony R Otley; Anne M Griffiths; Gilaad G Kaplan; Charles N Bernstein; Alain Bitton; Sanjay K Murthy; Geoffrey C Nguyen; Kate Lee; Jane Cooke-Lauder; Eric I Benchimol
Journal:  J Can Assoc Gastroenterol       Date:  2018-11-02

5.  Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses.

Authors:  Manasi Agrawal; João Sabino; Catarina Frias-Gomes; Christen M Hillenbrand; Celine Soudant; Jordan E Axelrad; Shailja C Shah; Francisco Ribeiro-Mourão; Thomas Lambin; Inga Peter; Jean-Frederic Colombel; Neeraj Narula; Joana Torres
Journal:  EClinicalMedicine       Date:  2021-05-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.